Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

SOLTIVE™ SuperPulsed Laser System shortens kidney stone procedure time, proves more cost-effective than Holmium: YAG, abstracts show

Two new independent abstracts suggest the SOLTIVE Laser System reduces procedure time on average 20% and offers the potential for greater patient outcomes

(PRNewsfoto/Olympus Medical Systems Group)

News provided by

Olympus

Jan 18, 2022, 09:20 ET

Share this article

Share toX

Share this article

Share toX

CENTER VALLEY, Pa., Jan. 18, 2022 /PRNewswire/ -- Olympus today announced abstract findings  of independent clinical studies that show the treatment of kidney stones with the SOLTIVE™ Premium SuperPulsed Laser System (SOLTIVE Laser System) may offer the potential for shorter procedure times, better patient outcomes and lower procedures costs than those performed with Holmium: YAG.

Continue Reading
Two new independent abstracts suggest the SOLTIVE(TM) SuperPulsed Laser System shortens kidney stone procedure time on average by 20% and offers the potential for greater patient outcomes
Two new independent abstracts suggest the SOLTIVE(TM) SuperPulsed Laser System shortens kidney stone procedure time on average by 20% and offers the potential for greater patient outcomes

The two abstracts noting these findings were published in the September edition of The Journal of Urology. They compared performing ureteroscopy and laser lithotripsy with Holmium: YAG versus Thulium Fiber Laser (TFL) and treatment of kidney stones in the upper urinary tract using Holmium: YAG versus TFL in dusting mode.

Launched in 2020, the SOLTIVE Laser System offers a new application of thulium fiber laser technology designed for stone lithotripsy, benign prostatic hyperplasia and other soft tissue applications. The SOLTIVE Laser's primary benefit is next-generation lithotripsy performance, dusting stones in half the time it takes the advanced post-modulation Holmium: YAG technology, creating a fine dust that is more easily passed through urine.1

As with non-laser surgery, the possibility of complications and adverse events, such as chills, fever, edema, hemorrhage, inflammation, tissue necrosis, or infection may occur following treatment. In extreme cases, death may occur due to procedural complications, concurrent illness, or laser application. As with any conventional surgery, acute pain may occur immediately following laser therapy and may persist for as long as 48 hours.

In the first abstract from the University of Maine Medical Center in Portland, Maine, physicians treated 51 patients each with Holmium: YAG and TFL.2 The operative time, measured from scope in to scope out, was on average nearly 13 minutes shorter per procedure with TFL compared to Holmium: YAG. Further analysis showed that cases with a cumulative stone diameter less than 15mm resulted in a procedure difference of nearly 14 minutes and the mean difference was more than 17 minutes for cases with a stone of less than 10mm.

The study concluded that TFL is a "substantially faster means of laser lithotripsy" than Holmium: YAG with average procedure time reduced by 20%.

"As the number of URS laser lithotripsy procedures being performed in the United States continues to increase, reducing procedure times has the potential to improve patient outcomes and decrease costs," according to the study.

The second abstract from the University of Rochester Medical Center in Rochester, N.Y., compared the efficiency and cost effectiveness of the SOLTIVE Laser System versus Holmium: YAG operating in the fixed dusting setting.3 The abstract included 62 patients divided evenly between the two procedures. There were no significant differences among the patients or kidney stones that measured between 10 and 30mm.

The abstract showed that procedures to remove kidney stones in the upper urinary tract performed with SOLTIVE were on average 2.6 minutes shorter than with Holmium: YAG. Procedures for kidney stones measuring less than 15mm were 3.4 minutes shorter and procedures with stones larger than 15mm were nearly 2 minutes shorter.

Researchers estimate a projected savings of $69 per procedure utilizing SOLTIVE, which was also superior in terms of stone-free rate, retropulsion, visibility and controlling bleeding, according to the study.

"Preliminary clinical data demonstrated the effectiveness of TLF in dusting kidney stones compared to 100W Ho:YAG laser (EMPOWER) at fixed laser settings," said Dr. Ahmed Ghazi, one of the researchers and an associate professor of urology at the University of Rochester Medical Center. "This new data based on patient procedures demonstrates the efficiency and cost effectiveness of TFL."

The efficiency of the SOLTIVE Laser System's laser fibers in breaking apart the stones is due to absorption in water. Its compact footprint is one-eighth of the size of other Holmium: YAG systems and runs more efficiently, requiring only a standard 110-volt power outlet.

"When Olympus launched the SOLTIVE Laser System, we were excited to offer an innovative laser technology that would provide urologists a tool to improve efficiencies and patient outcomes," said Patrick MacCarthy, Vice President of the Urology Business Unit for Olympus Corporation. "Now, we're excited to see the results of independent studies that show how SOLTIVE is lowering the times and costs of kidney stone procedures."

For more information about the SOLTIVE Laser System, visit: RockUroWorld.com.

About Olympus

Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment industries.

Olympus' Medical business uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of EndoTherapy instruments. For more information, visit medical.olympusamerica.com.

Disclaimer:  These abstract study findings are early analysis and may change with further, more complete analysis. Generalizability of economic impact to other institutions is not specific and is limited.

1 Benchmark study. Comparison of dusting and fragmenting using the new Super Pulse Thulium Fiber Laser to a 120W Holmium: YAG laser. AUA 2019. Dr. Ben Chew
2 Ryan, JR; Nguyen, MH; Linscott, JA; Nowicki, SW; Jumper, BM; Ingimarsson, JP; "PD54-07: Thulium Fiber Laser Results in Shorter Operating Times During Ureteroscopy and Laser Lithotripsy;" The Journal of Urology, September 2021; accessed Nov. 2, 2021.
3 Ghazi, A; Khalil, M; Feng, C; Quarrier, S; Jain, R. "PD54-08: Holmium: Yag (HO:YAG) Versus Thulium Fiber Laser (TFL) For Treatment Of Upper Urinary Tract Calculi In Dusting Mode: A Clinical Comparison Of Efficiency, Efficacy And Costs Effectiveness;" The Journal of Urology, September 2021; accessed Nov. 2, 2021.

SOURCE Olympus

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Olympus and W. L. Gore & Associates passe un accord de distribution internationale pour développer la gamme EndoTherapy d'Olympus

Olympus and W. L. Gore & Associates passe un accord de distribution internationale pour développer la gamme EndoTherapy d'Olympus

Olympus Corporation, une entreprise internationale des technologies médicales dédiée à rendre la vie des autres plus saine, plus sûre et plus...

Olympus e W. L. Gore & Associates stipulano un accordo di distribuzione internazionale per ampliare il portfolio EndoTherapy di Olympus

Olympus e W. L. Gore & Associates stipulano un accordo di distribuzione internazionale per ampliare il portfolio EndoTherapy di Olympus

Olympus Corporation, azienda globale del settore MedTech dedicata a rendere la vita delle persone più salutare, sicura e gratificante, ha stipulato...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

Clinical Trials & Medical Discoveries

Clinical Trials & Medical Discoveries

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.